Impact of Low Hematocrit on Heart Surgery Outcomes
Author Information
Author(s): Christian von Heymann, Michael Sander, Achim Foer, Anja Heinemann, Bruce Spiess, Jan Braun, Michael Krämer, Joachim Grosse, Pascal Dohmen, Simon Dushe, Jürgen Halle, Wolfgang F Konertz, Klaus-Dieter Wernecke, Claudia Spies
Primary Institution: Charité – University Hospital Berlin
Hypothesis
Does a hematocrit of 20% during cardiopulmonary bypass affect oxygen delivery and clinical outcomes in low-risk patients undergoing coronary artery bypass graft surgery?
Conclusion
A hematocrit of 20% during normothermic cardiopulmonary bypass maintained adequate oxygen delivery without negatively impacting clinical outcomes.
Supporting Evidence
- Oxygen delivery was maintained above critical levels during surgery.
- No significant differences in clinical outcomes were observed between the two hematocrit groups.
- The study suggests that lower hematocrit levels may be safe for low-risk patients.
Takeaway
Doctors tested if having less blood during heart surgery would still keep patients healthy. They found it did not cause problems.
Methodology
This was a prospective, randomized controlled trial comparing two hematocrit levels during cardiopulmonary bypass.
Potential Biases
The study included only low-risk patients, limiting generalizability to higher-risk populations.
Limitations
The sample size was small and may not be representative of all cardiac patients.
Participant Demographics
The majority of participants were men, with a small number of women.
Statistical Information
P-Value
p = 0.11 for oxygen delivery, p = 0.06 for oxygen consumption
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website